Results 11 to 20 of about 50,472 (297)
Frontiers in Oncology, 2013 Objective: To describe and synthesize the current stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) cost-effectiveness research to date across several common SRS and SBRT applications.
Akash eBijlani +3 more
doaj +1 more source
A current perspective on stereotactic body radiation therapy for pancreatic cancer. [PDF]
, 2016 Pancreatic cancer is a formidable malignancy with poor outcomes. The majority of patients are unable to undergo resection, which remains the only potentially curative treatment option.
Czito, Brian G +3 more
core +2 more sources
The Oncologist, EarlyView., 2021 Abstract Lessons Learned Osimertinib has confirmed effectiveness in this real‐world population of patients with EGFR‐mutant advanced non‐small cell lung cancer. Thromboembolic events occur more frequently than previously reported, suggesting a thrombotic diathesis that requires further investigation. Patients with at least three metastatic sites, brain
Martina Lorenzi +21 more
wiley +1 more source
Thoracic Cancer, 2023 Stereotactic body radiotherapy (SBRT), also known as stereotactic ablative radiotherapy (SABR), is commonly used in inoperable patients with early‐stage non‐small lung cancer (NSCLC).
Izabela Zarębska, Maciej Harat
doaj +1 more source
Stereotactic MRI-guided Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer: A Promising Approach. [PDF]
, 2018 Locally advanced pancreatic cancer (LAPC) is characterized by poor prognosis and low response durability with standard-of-care chemotherapy or chemoradiotherapy treatment.
Cao, Minsong +6 more
core +1 more source
SAGE Open Medical Case Reports, 2021 There are only a limited number of previous reports on clinical cases using tumour tracking with tomotherapy. Therefore, we present two cases of patients treated with tumour tracking with tomotherapy.
Wataru Okada +7 more
doaj +1 more source
A call for the aggressive treatment of oligometastatic and oligo-recurrent non-small cell lung cancer. [PDF]
, 2012 Metastatic non-small cell lung cancer (NSCLC) carries a dismal prognosis. Clinical evidence suggests the existence of an intermediate, or oligometastatic, state when metastases are limited in number and/or location.
Niibe, Yuzuru +4 more
core +3 more sources
Respiration-Induced Intraorgan Deformation of the Liver: Implications for Treatment Planning in Patients Treated With Fiducial Tracking. [PDF]
, 2017 Stereotactic body radiation therapy is a well-tolerated modality for the treatment of primary and metastatic liver lesions, and fiducials are often used as surrogates for tumor tracking during treatment. We evaluated respiratory-induced liver deformation
Anwar, Mekhail +7 more
core +1 more source
Stereotactic Body Radiotherapy
RADIOISOTOPES, 2012 定位放射線治療は，「小腫瘍に対して高精度に短期で3次元的に集中的大線量を投与する」と定義され，「切らずに治す」ことが可能となった。体幹部定位照射は，(1)1990年代半ばから急速に発展した照射装置の進歩，(2)固定精度の向上，(3)画像誘導技術，(4)呼吸性移動対策などによって，周囲臓器への危険を回避しながら腫瘍への投与線量を上げることが可能になり実現した。定位放射線治療は頭蓋内では約40年の歴史があるが，体幹部病変は固定法・呼吸性移動・線量計算の問題点によりまだ15年程度の経験しかない。それにもかかわらず，小型の肺癌・肺転移・肝腫瘍を中心に安全性と有効性について定位放射線治療の多くの臨床経験が積まれつつあり，特にもっとも治療経験が蓄積されているI期肺癌では ...
Hiroshi ONISHI +14 more
openaire +2 more sources
Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?
Clinical and Translational Radiation Oncology, 2019 Renal cell carcinoma (RCC) has traditionally been regarded as radioresistant tumor based on preclinical data and negative clinical trials using conventional fractionated radiotherapy. However, there is emerging evidence that radiotherapy delivered in few
Alexander Rühle +3 more
doaj +1 more source